About Abbvie Inc

AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. The Company strives to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio.

CEO

Richard Gonzalez

Employees

2022

Headquarters

1 N Waukegan Rd
North Chicago, Illinois 60064-1802
Phone: 18479327900
www.abbvie.com

News

Baker Tilly Wealth Management LLC Lowers Stock Position in AbbVie Inc. (NYSE:ABBV)
Oct 02, 2023 16:38pm

Baker Tilly Wealth Management LLC lowered its stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 3.6% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 16,982 shares of the company’s stock after selling 629 shares during the quarter. Baker […]

Source:The AM Reporter

AbbVie faces interchangeable Humira biosimilar at 81% discount
Oct 02, 2023 13:09pm

German drugmaker Boehringer Ingelheim launched an interchangeable biosimilar to AbbVie''s Humira at an 81% discount, joining other companies in offering…

Source:Seeking Alpha

Newron Pharmaceuticals S.p.A.: Newron Appoints Margarita Chavez as Board Advisor
Oct 02, 2023 11:06am

Margarita Chavez, former Managing Director at AbbVie Ventures, to be nominated for election to the Board of Directors at the Ordinary AGM 2024 Newron Pharmaceuticals S.p.A. ("Newron") (SIX: NWRN, …

Source:Finanz Nachrichten

AbbVie Inc. (NYSE:ABBV) Shares Sold by Sumitomo Life Insurance Co.
Sep 30, 2023 15:26pm

Sumitomo Life Insurance Co. cut its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 8.8% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 26,071 shares of the company’s stock after selling 2,524 shares during the period. Sumitomo Life Insurance Co.’s […]

Source:The AM Reporter

Blackston Financial Advisory Group LLC Sells 339 Shares of AbbVie Inc. (NYSE:ABBV)
Sep 30, 2023 13:52pm

Blackston Financial Advisory Group LLC lowered its … shares during the quarter. Blackston Financial Advisory Group LLC’s holdings …

Source:EIN News Finance

Pharma Stock Roundup: FDA and EMA Regulatory Updates for ABBV, LLY, SNY & MRK’s Drugs
Sep 30, 2023 02:37am

Featured stocks include AbbVie and Johnson & Johnson.

Source:24/7 Wall street

AbbVie''s Promising Leap Towards Long-Term Growth: Analyst
Sep 29, 2023 17:37pm

Raymond James initiated coverage on AbbVie Inc (NYSE: ABBV ) as the company looks beyond Humira''s loss of exclusivity and has several levers to set up long-term growth. Analysts Gary Nachman and Denis Reznik have initiated with an Outperform rating and a price target of $177 . ABBV is showcasing resilience and adaptability, adeptly navigating the U.S. loss of exclusivity (LOE) for Humira, surpassing initial projections . The portfolio diversification, complemented by Skyrizi and Rinvoq''s multi-indication approval, paints a promising Full story available on Benzinga.com

Source:Benzinga

Ionis, AbbVie, Alnylam draw bullish views at Raymond James
Sep 29, 2023 17:05pm

Raymond James initiated coverage on Ionis Pharmaceuticals, AbbVie, and Alnylam Pharmaceuticals with buy-equivalent ratings. Read more here.

Source:Seeking Alpha

4 stocks to watch on Friday: Carnival Corp, AbbVie and more
Sep 29, 2023 13:08pm

Carnival Corp (CCL), BlackBerry (BB), AbbVie (ABBV) and Restaurant Brands International (QSR) are the stocks to watch on Friday.

Source:Seeking Alpha

AbbVie blood cancer therapy fails in Phase 3 trial
Sep 29, 2023 12:18pm

AbbVie''s blood cancer therapy venetoclax did not meet its primary endpoint in a Phase 3 trial for multiple myeloma. Read more here.

Source:Seeking Alpha